Cargando…
Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
Pancreatic cancer remains a disease with unmet clinical needs and inadequate diagnostic, prognostic, and predictive biomarkers. In-depth characterization of the disease proteome is limited. This study thus aims to define and describe protein networks underlying pancreatic cancer and identify protein...
Autores principales: | Silwal-Pandit, Laxmi, Stålberg, Stina M., Johansson, Henrik J., Mermelekas, Georgios, Lothe, Inger Marie B., Skrede, Martina L., Dalsgaard, Astrid Marie, Nebdal, Daniel J. H., Helland, Åslaug, Lingjærde, Ole Christian, Labori, Knut Jørgen, Skålhegg, Bjørn S., Lehtiö, Janne, Kure, Elin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010336/ https://www.ncbi.nlm.nih.gov/pubmed/36923555 http://dx.doi.org/10.1158/2767-9764.CRC-21-0100 |
Ejemplares similares
-
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022) -
The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
por: Öjlert, Åsa Kristina, et al.
Publicado: (2019) -
Opportunities of improvement in the management of pancreatic and periampullary tumors: Prospective evaluation of outcome from a multidisciplinary research program
por: Nordby, Tom, et al.
Publicado: (2013) -
Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018) -
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)